Catch up on the most viewed content at Diagnostic imaging in July 2023.
Our top five content in July ranged from a breakdown of new research about the rise of non-physician practitioner (NPP) imaging interpretation to our coverage of the SNMMI 2023 conference, including research about the use of an emerging PET radiotracer to detect coronary artery disease in obese patients and the promise of ultra-high resolution (UHR) brain PET. Review the slideshow below to see this month's top content.
Emerging PET/CT Agent May Enhance Diagnosis for Smaller Lesions of Clear Cell Renal Cell Carcinoma
September 20th 2023For cT1 renal masses < 4 cm and renal masses < 2 cm, the PET/CT agent 89Zr-DFO-girentuximab had respective sensitivity rates of approximately 85 percent and 96.7 percent for diagnosing clear cell renal cell carcinoma, according to research recently presented at the European Association of Nuclear Medicine (EANM) 2023 Congress.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Significant Overutilization of Head and Neck CT Angiography in the ER
September 18th 2023Over 80 percent of head and neck computed tomography angiography (CTA) exams performed in the emergency department had no actionable findings for patients with non-focal neurologic complaints, and 67 percent of the exams were ordered by non-physician practitioners (NPPs), according to a newly published study.
2 Clarke Drive
Cranbury, NJ 08512